AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FENNEC PHARMACEUTICALS INC. Director's Dealing 2017

Sep 13, 2017

35599_dirs_2017-09-13_a77d8c53-13c6-427f-b815-48cf4c717737.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2017-09-11

Reporting Person: Southpoint Master Fund, LP (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3997214	Direct

Footnotes

F1: This amendment is being filed to add Southpoint Master Fund, LP as a Reporting Person to the Form 3 filed on September 11, 2017 by Southpoint Capital Advisors LP, Southpoint Capital Advisors LLC, Southpoint GP, LP, Southpoint GP, LLC, and John S. Clark II.